Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q1 2024

European Healthtech startup funding raised during Q1 2024.

In Q1 2024, 124 European Healthtech companies closed 124 funding rounds and raised €930M in equity funding (excluding debt and grants), down 33.7% versus Q1 2023. Debt rounds added €24M. UK led by capital raised, and The Future of Health Grant (FoHG) program was the most active investor. Data as of 20 Nov 2026.

Equity funding
€930M
-33.7% vs Q1 2023 · excl. debt & grants · +€24M debt
Funding rounds
124
-29.9% vs Q1 2023
Companies
124
Top country
UK
Rank among sectors
#6
3.3% of sector funding
Debt financing
€24M
2.5% of total
Top-10 round share
46.2%
of disclosed capital
Rounds ≥ €100M
1

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q1 2024 — interactive chart.
Data table
FundingRounds
Jan€423M39
Feb€328M56
Mar€216M29

Top countries

by € raised
Healthtech — top countries by capital, Q1 2024 — interactive chart.
Data table
Healthtech — top countries by capital, Q1 2024
UK€214M
Switzerland€183M
Germany€124M
Italy€112M
France€110M
Finland€85M
Netherlands€40M
Spain€13M

Stage mix

by € raised
Healthtech — stage mix, Q1 2024 — interactive chart.
Data table
Healthtech — stage mix, Q1 2024
Other€263M
Series B€186M
Series C€132M
Series A€128M
Series D+€99M
Seed€82M
Growth/Late€32M
Debt€24M
Grant€14M
Pre-Seed€8.1M

Exits & M&A

10 Acquisition

10 exits · €437M disclosed.

Calypso BiotechAcquisitionJan 2024€425M
ApoteaAcquisitionJan 2024€12M

Top deals

largest disclosed rounds in Q1 2024
CompanyStageDateAmount
MMISeries CFeb 2024€102M
TimelineSeries D+Jan 2024€61M
Infinite Roots (Mushlabs)Series BJan 2024€53M
Bob WSeries BFeb 2024€40M
PhagenesisSeries D+Mar 2024€39M
Relation TherapeuticsSeedMar 2024€32M
Enterprise TherapeuticsSeries BJan 2024€30M
AqemiaSeries AJan 2024€30M
Onera HealthSeries CJan 2024€30M
ProtembisSeries BMar 2024€30M
Hilo (Aktiia)OtherFeb 2024€28M
icotecGrowth/LateJan 2024€28M
LEM SurgicalSeries BJan 2024€24M
SpineartDebtMar 2024€21M
KinventOtherJan 2024€16M

Top investors

most active in Q1 2024, by deal count